Back to Trades
BORMANN-KENNEDY BARBARA-JEAN ANNE
DirectorCIK 0001635065
Total Volume
$406.8K
2 filings
Purchases
$0
0 buy txns
Sales
$203.9K
2 sell txns
Net Activity
-$203.9K
net sold
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2025–2026
BORMANN-KENNEDY BARBARA-JEAN ANNE, Director, has filed 2 SEC reports (2025–2026), all concentrated in Xeris Biopharma Holdings, Inc. (XERS), totaling $406.8K in disclosed volume. Weighing $0 bought versus $203.9K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Jun 5 | XERS Xeris Biopharma Holdings, Inc. | BORMANN-KENNEDY BARBARA-JEAN ANNE | Director | Sell | $97.5K |
| Dec 15 | XERS Xeris Biopharma Holdings, Inc. | BORMANN-KENNEDY BARBARA-JEAN ANNE | Director | Sell | $106.4K |
2 filings